Benefits
Blood pressure reduction
A meta-analysis of 12 RCTs demonstrates aged garlic extract significantly reduces systolic blood pressure by 8.3 mmHg and diastolic by 5.5 mmHg — effects comparable to first-line antihypertensive medications in hypertensive patients. The ACE-inhibitory and nitric oxide-enhancing properties of garlic organosulfur compounds drive this clinically meaningful reduction.
Cholesterol and cardiovascular protection
Garlic supplementation significantly reduces total cholesterol (by 10–15 mg/dL), LDL oxidation, and platelet aggregation in meta-analyses of multiple RCTs. Aged garlic extract reduces arterial stiffness, slows carotid intima-media thickness progression, and reduces coronary artery calcium score — direct measures of atherosclerotic disease progression.
Antimicrobial and immune activity
Allicin exhibits broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, fungi (including Candida), and viruses including influenza. AGE supplementation increases NK cell activity, enhances macrophage function, and reduces the frequency and duration of colds and flu in clinical studies.
Blood sugar regulation
Garlic significantly reduces fasting blood glucose, HbA1c, and insulin resistance in type 2 diabetic patients. Multiple mechanisms include alpha-glucosidase inhibition, improved insulin sensitivity via AMPK activation, and protection of pancreatic beta cells from oxidative damage — supporting garlic as a meaningful adjunct in metabolic health.
Cancer chemoprevention
Extensive epidemiological and mechanistic data supports garlic's cancer-preventive properties — particularly for gastric, colorectal, and prostate cancers. Allicin and its metabolites induce apoptosis in cancer cells, inhibit cell proliferation, reduce carcinogen activation, and enhance carcinogen detoxification via phase II enzyme induction.
Mechanism of action
Allicin and organosulfur compound formation
When garlic is crushed or chopped, the enzyme alliinase converts alliin to allicin (diallyl thiosulfinate) — a volatile, sulfur-rich compound with potent biological activity. Allicin rapidly degrades to secondary organosulfur compounds (diallyl disulfide, diallyl trisulfide, ajoene) that enter circulation and exert cardiovascular, antimicrobial, and anticancer effects.
eNOS activation and nitric oxide production
Garlic organosulfur compounds activate endothelial nitric oxide synthase (eNOS), increasing bioavailable nitric oxide and promoting vasodilation, reducing blood pressure, and improving endothelial function — the same fundamental mechanism as pharmaceutical ACE inhibitors and nitrate drugs.
HMG-CoA reductase and platelet aggregation inhibition
S-allylcysteine inhibits HMG-CoA reductase (the statin target), reducing cholesterol synthesis. Ajoene and allicin inhibit platelet aggregation by reducing thromboxane A2 synthesis and interfering with fibrinogen binding to glycoprotein IIb/IIIa receptors — reducing thrombotic cardiovascular risk through dual lipid and platelet mechanisms.
Clinical trials
Pooled analysis of randomized controlled trials examining aged garlic extract (AGE) effects on blood pressure in hypertensive patients. (J Clin Hypertens; or related Ried pooled analyses)
Pooled across multiple clinical trials.
AGE significantly reduced systolic BP by ~7-10 mmHg and diastolic BP by ~5 mmHg vs placebo in hypertensive patients. Effects comparable to first-line antihypertensives in magnitude. Aged garlic extract (e.g., Kyolic®) is the most-studied form for cardiovascular applications. Note: garlic intervention should not replace established antihypertensive therapy in hypertensive patients but may be useful adjunct.
Randomized, double-blind trial of aged garlic extract (Kyolic® AGE, 1,200 mg/day) vs placebo in 55 intermediate cardiovascular risk patients over 1 year. Outcomes: coronary artery calcium (CAC) score progression, pericardial fat, inflammatory markers. (J Nutr; or)
55 intermediate CV risk patients. 1-year intervention.
AGE significantly slowed coronary artery calcium progression and reduced pericardial fat vs placebo. Modest reductions in homocysteine and inflammatory markers. Small trial; encouraging signal but should not be considered definitive evidence for plaque modulation.
Randomized, double-blind, placebo-controlled trial of AGE (Kyolic®, 2.56 g/day) vs placebo in 120 healthy adults during 90-day cold and flu season. Outcomes: cold incidence, sick days, NK cell activity, gamma-delta T-cell function. (Clin Nutr)
120 healthy adults during cold/flu season.
AGE group had reduced cold/flu severity (number of symptoms, days sick) vs placebo, with significantly enhanced NK cell activity and gamma-delta T-cell proliferation. Industry-funded. Adds to evidence for immune-modulatory effects of AGE.